Infectious Etiology of Vomiting in Children With Presumed Acute Gastroenteritis

Sponsor
Medical University of Warsaw (Other)
Overall Status
Recruiting
CT.gov ID
NCT05270291
Collaborator
(none)
198
1
31
6.4

Study Details

Study Description

Brief Summary

In children with acute gastroenteritis (AGE), vomiting often precedes diarrhea. To establish the diagnosis of AGE, enteropathogen detection typically relies on diarrheal stool samples. However, testing requires sufficient stool sample, which may not be easily available. Recent studies suggest that in children presenting to emergency departments with presumed AGE with isolated vomiting, an enteropathogen can be identified using rectal swabs and molecular diagnostic tests. The rate of enteropathogen detection in children with isolated vomiting due to AGE may differ in various populations. Using rectal swabs and molecular diagnostic tests, we plan to assess the proportion of children with isolated vomiting with presumed AGE in whom an enteropathogen can be identified.

This will be a prospective cohort study. Children younger than 5 years with presence of ≥3 episodes of vomiting due to presumed AGE, lasting no longer than 7 days before enrolment, will be recruited. A total of 198 participants will be recruited and a rectal swab will be collected. The participants will be contacted 14 days after enrollment to complete a survey regarding symptoms experienced during that period and to identify any additional clinical care.

Condition or Disease Intervention/Treatment Phase
  • Procedure: rectal swab

Study Design

Study Type:
Observational
Anticipated Enrollment :
198 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Infectious Etiology of Vomiting in Children With Presumed Acute Gastroenteritis in the Absence of Diarrhea
Actual Study Start Date :
May 1, 2022
Anticipated Primary Completion Date :
Apr 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Outcome Measures

Primary Outcome Measures

  1. The proportion of children with isolated vomiting with presumed AGE in whom an enteropathogen can be identified. [immediately after the procedure]

Secondary Outcome Measures

  1. Types of pathogens detected based on presenting symptoms [immediately after the procedure]

  2. The proportion of children with isolated vomiting with alternative diagnosis [immediately after procedure]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 5 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age 0-5-year-old

  • presence of ≥3 episodes of vomiting due to presumed AGE at inclusion

  • <7 days of symptoms at the time of inclusion

  • signed written informed consent

Exclusion Criteria:
  • anticipated inability to complete 14 days follow-up

  • history of neutropenia (as rectal swabs are contraindicated)

  • critically ill status requiring urgent medical intervention

  • inability to provide a rectal swab for testing

  • chronic gastrointestinal tract disorders such as inflammatory bowel disease, cystic fibrosis, coeliac disease

  • immunodeficiency

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University of Warsaw Warsaw Mazovian Poland 02-091

Sponsors and Collaborators

  • Medical University of Warsaw

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hanna Szajewska, Profesor, Medical University of Warsaw
ClinicalTrials.gov Identifier:
NCT05270291
Other Study ID Numbers:
  • Isolated vomiting etiology
First Posted:
Mar 8, 2022
Last Update Posted:
Jun 28, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hanna Szajewska, Profesor, Medical University of Warsaw
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 28, 2022